Novavax Reports Third Quarter 2020 Financial and Operational Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Novavax (NVAX) Reports Q3 Loss of $3.21/sh
November 9, 2020 4:34 PM ESTNovavax (NASDAQ: NVAX) reported Q3 EPS of ($3.21), versus $0.74 reported last year. Revenue for the quarter came in at $157 million versus the consensus estimate of $230.56 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
... More
